| TIL |
Instil Bio, Inc. |
159.49M |
3.59% |
|
|
|
|
|
24.44 |
4.62% |
576.12% |
75.97% |
|---|
| REPL |
Replimune Group, Inc. |
756.01M |
3.54% |
|
|
|
|
|
11.05 |
-1.60% |
72.67% |
3.63% |
|---|
| IOVA |
Iovance Biotherapeutics, Inc. |
2.51B |
3.47% |
|
|
|
|
|
8.25 |
1.35% |
75.07% |
11.76% |
|---|
| ZYME |
Zymeworks Inc. |
954.64M |
3.45% |
|
|
|
|
|
13.86 |
-4.74% |
71.74% |
18.58% |
|---|
| ARGX |
argenx SE |
35.63B |
3.42% |
|
|
|
|
|
590.27 |
-0.26% |
28.29% |
24.20% |
|---|
| GMAB |
Genmab A/S |
13.05B |
3.42% |
|
|
|
|
|
20.55 |
0.46% |
197.41% |
10.44% |
|---|
| AZN |
AstraZeneca PLC |
197.80B |
3.39% |
|
|
|
|
|
63.80 |
0.94% |
28.18% |
63.14% |
|---|
| BMY |
Bristol-Myers Squibb Company |
118.36B |
3.39% |
|
|
|
|
|
58.36 |
0.83% |
23.50% |
21.98% |
|---|
| CRSP |
CRISPR Therapeutics AG |
3.95B |
3.39% |
|
|
|
|
|
46.24 |
-2.16% |
58.15% |
26.37% |
|---|
| MRK |
Merck & Co., Inc. |
251.42B |
3.37% |
|
|
|
|
|
99.39 |
2.00% |
24.16% |
48.53% |
|---|
| NKTR |
Nektar Therapeutics |
184.68M |
3.37% |
|
|
|
|
|
1.0012 |
0.12% |
739.76% |
39.53% |
|---|
| XNCR |
Xencor, Inc. |
1.68B |
3.37% |
|
|
|
|
|
24.02 |
1.27% |
66.38% |
43.09% |
|---|
| REGN |
Regeneron Pharmaceuticals, Inc. |
80.84B |
3.36% |
|
|
|
|
|
748.00 |
0.63% |
30.89% |
66.05% |
|---|
| FATE |
Fate Therapeutics, Inc. |
233.49M |
3.33% |
|
|
|
|
|
2.0501 |
-7.65% |
348.27% |
42.40% |
|---|
| GILD |
Gilead Sciences, Inc. |
111.52B |
3.33% |
|
|
|
|
|
89.48 |
0.96% |
25.32% |
34.87% |
|---|
| RCUS |
Arcus Biosciences, Inc. |
1.31B |
3.32% |
|
|
|
|
|
14.27 |
-2.39% |
84.51% |
32.25% |
|---|
| ATRA |
Atara Biotherapeutics, Inc. |
59.96M |
3.30% |
|
|
|
|
|
10.41 |
-2.53% |
769.79% |
94.72% |
|---|
| ALLO |
Allogene Therapeutics, Inc. |
439.26M |
3.29% |
|
|
|
|
|
2.0950 |
2.19% |
366.65% |
62.66% |
|---|
| RUBY |
Rubius Therapeutics, Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
|---|
| TRIL |
Trillium Therapeutics Inc. |
|
3.29% |
|
|
|
|
|
|
|
|
|
|---|
| BLUE |
bluebird bio, Inc. |
58.53M |
3.28% |
|
|
|
|
|
0.3010 |
-0.66% |
652.55% |
46.13% |
|---|
| IBRX |
ImmunityBio, Inc. |
3.49B |
3.28% |
|
|
|
|
|
5.02 |
2.87% |
99.23% |
16.24% |
|---|
| IMAB |
I-Mab |
71.40M |
3.25% |
|
|
|
|
|
0.9270 |
-5.40% |
312.28% |
58.29% |
|---|
| IGMS |
IGM Biosciences, Inc. |
523.09M |
3.23% |
|
|
|
|
|
8.80 |
-9.91% |
188.93% |
27.21% |
|---|
| STTK |
Shattuck Labs, Inc. |
48.46M |
3.23% |
|
|
|
|
|
1.0150 |
-8.56% |
622.62% |
69.78% |
|---|
| ALXO |
ALX Oncology Holdings Inc. |
67.51M |
3.21% |
|
|
|
|
|
1.2800 |
5.79% |
481.91% |
22.03% |
|---|
| LEGN |
Legend Biotech Corporation |
7.27B |
3.20% |
|
|
|
|
|
39.63 |
-1.27% |
65.33% |
48.62% |
|---|
| BGNE |
BeiGene, Ltd. |
21.51B |
3.19% |
|
|
|
|
|
193.42 |
-0.43% |
40.40% |
31.73% |
|---|
| MGNX |
MacroGenics, Inc. |
201.47M |
3.17% |
|
|
|
|
|
3.21 |
-2.13% |
63.37% |
4.18% |
|---|
| YMAB |
Y-mAbs Therapeutics, Inc. |
453.19M |
3.12% |
|
|
|
|
|
10.12 |
-4.00% |
15.86% |
45.11% |
|---|
| Cash&Other |
|
|
0.13% |
|
|
|
|
|
|
|
|
|
|---|